Stem Cells

Extensive optimization and genetic instability make stem and primary cells notoriously challenging to engineer. Collaborating with MaxCyte® can streamline your development process and ensure success. Highly efficient electroporation and high cell viabilities reduce optimization time and cost, providing the ideal solution.

Ensure highly efficient gene editing

Stem cells have enormous potential for regenerative medicine and disease modeling. The key to their utility, however, is efficient genetic engineering. Low-efficiency editing can result in time-consuming and costly screening. MaxCyte’s electroporation is gentle on cells ensuring high viability, which facilitates high-frequency targeted gene editing. Partner with MaxCyte for effortless engineering in challenging cells.


Optimized plasmid delivery in hiPSCs.

Efficient delivery ensures effortless optimization

Let MaxCyte streamline your transfection workflow with highly efficient delivery of diverse payloads. Rely on our superior performance to save you time and money on experimental optimization. With MaxCyte, you can focus on what counts, moving your discovery from concept to clinic.

MaxCyte empowers innovative stem cell research

Stem cells have tremendous potential to transform human health. Their unique ability to differentiate into any cell type make them essential for disease modeling, drug screening and regenerative medicine research. MaxCyte is proud to collaborate with leading researchers and innovators to develop the next generation of stem cell therapies, diagnostics and models for a wide variety of diseases.

Research applications

Cell Therapy

Discover scalable engineering to enable safe and potent cell therapies.

Gene Editing

Navigate the complexities of genome engineering with highly efficient delivery.


Scientific Brief
Highly Efficient Homozygous Correction of the DYSF Gene in Miyoshi Myopathy Patient iPSCs by ssODN-Mediated Knockin.
Non-Viral Engineering of Human iPSCs to Manufacture Rejuvenated TCR T Cells for Cancer Immunotherapy.
Scientific Brief
Off-Target Effects of CRISPR-Cas9 Gene Editing in Human Hematopoietic Stem and Progenitor Cells.
View All Resources

Electroporation Systems

Supported by numerous publications and clinical trials, our ExPERT GTx® instrument is the next generation of the industry’s leading, scalable electroporation technology for complex cell engineering.

The GTxTM is capable of high-performance delivery of virtually any molecule, into any cell, at any scale with the unique ability to transfect primary cells, stem cells and cell lines with high cell viability and transfection efficiencies routinely over 90%.


Reagents and Processing Assemblies

MaxCyte’s consumable products provide users with a variety of options for project scale and throughput from discovery through cGMP manufacturing using a single platform. Our range of Processing Assemblies allows users to transfect a variety of cell sample volumes to meet specific application needs. MaxCyte’s Electroporation Buffer is animal-derived component free and safe for all cell types ensuring consistent, high-performance transfection.

Want to learn more about our Technology?

Our experienced team is here to help.

MaxCyte_Illustrations_Instrument + Person